The Committee on Congresses and Conferences was established in December 2007, and is the continuation of the former Congress and Conference Division (CCD) which was founded in 1996, but with an expanded charter and responsibilities. The C-CC has the major administrative and managerial responsibility within the IFCC for all meetings coordinated by the IFCC.
The mission of the C-CC is to provide general administration and management of all IFCC meeting activities (congresses, conferences, and symposia) and to review applications for IFCC auspices from non-IFCC conferences requesting such sponsorship.
The C-CC supports and promotes Clinical Laboratory Sciences through congresses, conferences, specialised meetings, and other professional meetings. The C-CC Works closely with the organisers of the various IFCC related conferences to ensure that they achieve organisational and professional excellence.
The C-CC formulates and updates as required the guidelines, procedures and practices for IFCC-designated meetings and also monitors compliance throughout the planning and organizational stages. The C-CC assists the organizing groups in the administration and promotion of conferences, and helps these conferences obtain support, and achieve financial efficiency in the various economical aspects of their meetings.
The C-CC reviews all existing meeting guidelines every three years to ensure their continued applicability and will write new guidelines for those meetings not covered by existing procedures.
The C-CC maintains a current 5-year listing of congresses and conferences of professional interest to the members of the IFCC, including both IFCC related conferences and those outside the IFCC. This allows members to be aware of these meetings and allows potential conference organisers to plan the dates of their meetings with care.
The C-CC designates as official IFCC approved meetings those conferences that conform to the requirements of the IFCC as a professional organisation, in order to promote the field of clinical laboratory sciences and protect the interests of the IFCC. Within the framework of the IFCC designated meetings, the C-CC will promote the IFCC and its functional units and discuss the possibility of integration of IFCC units and members in the programme of the conference.
The C-CC assists in expanding the list of IFCC Master Conferences on specific scientific and educational topics and promotes the leadership role of the IFCC in the field of Clinical Laboratory Sciences.
Name | Position | Country | Term | Time in Office |
P.Laitinen | Chair | FI | 1st | 2021 01 - 2023 12 |
M. Blanes Gonzales | Member | PY | 2nd | 2021 01 - 2023 12 |
A. Buňo Soto | Member | ES | 1st | 2021 01 -2023 12 |
C. Jackson | Corporate Member | US | 2nd | 202101 - 2023 12 |
J. Wesenberg | Consultant | CA | ||
A.Cano Huizar | Corresponding Member | MX | ||
W.H. Fang | Corresponding Member | TW | ||
J.Kumalawati | Corresponding Member | ID | ||
H. Martin | Corresponding Member | AU | ||
S.Robinson | Corresponding Member | UK | ||
C.Tsatsanis | Corresponding Member | GR | ||
A.Sepici Dincel | Corresponding Member | TR |
I | Amsterdam (NL) | 1954 |
II | New York (US) | 1956 |
III | Stockholm (SE) | 1957 |
IV | Edinburgh (UK) | 1960 |
V | Detroit (US) | 1963 |
VI | Munich (DE) | 1966 |
VII | Geneva/Evian (CH/FR) | 1969 |
VIII | Copenhagen (DK) | 1972 |
IX | Toronto (CA) | 1975 |
X | Mexico City (MX) | 1978 |
XI | Vienna (AT) | 1981 |
XII | Rio de Janeiro (BR) | 1984 |
XIII | The Hague (NL) | 1987 |
XIV | San Francisco (US) | 1990 |
XV | Melbourne (AU) | 1993 |
XVI | London (UK) | 1996 |
XVII | Florence (IT) | 1999 |
XVIII | Kyoto (JP) | 2002 |
XIX | Orlando (US) | 2005 |
XX | Fortaleza (BR) | 2008 |
XXI | Berlin (DE) | 2011 |
XXII | Istanbul (TR) | 2014 |
XXIII | Durban (ZA) | 2017 |
XXIV | Seoul (KR) | 2022 |
XXV | Rome (IT) | 2023 |
III | Singapore (SG) | 1986 |
IV | Hong Kong (HK) | 1988 |
V | Kobe (JP) | 1991 |
VI | Melbourne (AU) | 1993 |
VII | Bangkok (TH) | 1995 |
VIII | Kuala Lumpur (MY) | 1998 |
IX | New Dehli (IN) | 2001 |
X | Perth (AU) | 2004 |
XI | Beijing (CN) | 2007 |
XII | Seoul (KR) | 2010 |
XIII | Bali (ID) | 2013 |
XIV | Taiwan (TW) | 2016 |
XV | Jaipur (IN) | 2019 |
XVI | Sydney (AU) | 2022 |
I | Munich (DE) | 1974 |
II | Prague (CZ) | 1976 |
III | Brighton (UK) | 1979 |
IV | Vienna (AT) | 1981 |
V | Budapest (HU) | 1983 |
VI | Jerusalem (IL) | 1985 |
VII | Den Hague (NL) | 1987 |
VIII | Milan (IT) | 1989 |
IX | Crakow (PL) | 1991 |
X | Nice (FR) | 1993 |
XI | Tampere (FI) | 1995 |
XII | Basel (CH) | 1997 |
XIII | Florence (IT) | 1999 |
XIV | Prague (CZ) | 2001 |
XV | Barcelona (ES) | 2003 |
XVI | Glasgow (UK) | 2005 |
XVII | Amsterdam (NL) | 2007 |
XVIII | Innsbruck (AT) | 2009 |
XIX | Berlin (DE) (with ICCCLM 2011) | 2011 |
XX | Milan (IT) | 2013 |
XXI | Paris (FR) | 2015 |
XXII | Athens (GR) | 2017 |
XXIII | Barcelona (ES) | 2019 |
XXIV | Munich | 2021 |
S.to Domingo (DO) | 1991 |
Acapulco (MX) | 1993 |
Buenos Aires (AR) | 1995 |
Caracas (VE) | 1997 |
Puerto Rico (PR) | 1999 |
Florianopolis (BR) | 2001 |
San José (CR) | 2003 |
Asunciòn (PA) | 2006 |
Panama (PAN) | 2007 |
Santiago (CL) | 2010 |
Punta Cana (DO) | 2011 |
Lima (PE) | 2013 |
Quito (EC) | 2015 |
Punta del Este (UY) | 2017 |
Panama (PA) | 2019 |
Leon (MX) | 2022 |
Cairo (EG) | 1974 |
Faihaa (SY) | 1976 |
Cairo (EG) | 1980 |
Cairo (EG) | 1983 |
Cairo (EG) | 1986 |
Tunis (TN) | 1991 |
Faihaa (SY) | 1994 |
Amman (JO) | 1997 |
Rabat (MA) | 2000 |
Monastir (TU) | 2004 |
Damascus (SY) | 2006 |
Beirut (LB) | 2009 |
Marrakesh (MA) | 2012 |
Karthoum (SD) | 2015 |
Palestine (PS) | 2018 |
Beirut (LB) | 2021 |
Ibadan (NG) | 2009 |
Nairobi (KE) | 2011 |
Harare (ZW) | 2015 |
Marrakesh (MA) | 2019 |
Lusaka (ZM) | 2021 |
Terms of Reference
Recent Conferences:
VII | 1999 | Biochemical markers for myocardial damage |
VIII | 2001 | Biochemical markers of autoimmune disease |
IX | 2003 | Nucleic acid markers for bacterial and viral infections in intensive care |
X | 2005 | Diabetes and cardiovascular disease |
XI | 2008 | Markers of kidney disease |
XII | 2010 | Novel biomarkers: from discovery to clinical application |
XIII | 2012 | Vitamin D in health and disease |
XIV | 2014 | Women's Health |
XV | 2016 | Biomarkers in the Diagnosis and Monitoring of Cancer |
The following documents have been prepared by the C-CC.
Aim
The aim of the IFCC General Conference is to convene all the IFCC functional units at one time and location, in order to discuss present activities and projects, and to plan and decide on future actions of the organization.
Responsibilities
Time and Venue
Scope
Conferences:
I | Rungestedgaard (DK) | 1981 |
II | Rungestedgaard (DK) | 1984 |
III | Monza (IT) | 1988 |
IV | Pont-à-Mousson (FR) | 1992 |
V | Leipzig (DE) | 1995 |
VI | Sevilla (ES) | 1998 |
VII | Dubrovnik (HR) | 2001 |
VIII | Sousse (TN) | 2004 |
IX | Antalya (TR) | 2008 |
X | Corfu (GR) | 2010 |
XI | Kuala Lumpur (MY) | 2012 |
XII | Madrid (ES) | 2016 |
XIII | Budapest (HU) | 2018 |
Chair:
Prof. Paivi LAITINEN
Adjunct Professor
HUS Diagnostic Center
HUSLAB Clinical Chemistry
Topeliuksenkatu 32, P.O. Box 720
FI-0029 HUS, Helsinki
FINLAND
e-mail:paivi.h.laitinen@hus.fi
Members:
Dr. Antonio BUÑO SOTO
Department of Laboratory Medicine
University Hospital La Paz
Paseo de la Castellana 261
28046 Madrid
SPAIN
e-mail:antoniobuno@gmail.com
Prof. Montserrat BLANES GONZALES
Dept.of Medical Education and Research
Central Hospital
Paraguayan Social Security Institute
Av.da Sacramento y Dr Peña
1209, Asuncion, Paraguay
e-mail: mblanes@ips.gov.py
Corporate Member:
Mrs. Cheryl JACKSON
Global Marketing Technology and Sales Education
Beckman Coulter Diagnostics
200 South Kraemer Boulevard
Brea, CA 92821, USA
e-mail: cbjackson@beckman.com
Consultant:
Prof. James WESENBERG
Clinical Laboratory
Red Deer Regional Hospital Center
3942 50A Avenue
Red Deer, Alberta, T4N 4E7, Canada
e-mail: wesenberg@msn.com
Corresponding Members:
Prof. Woei-horng FANG
Dept of Clinical Laboratory Sciences
and Medical Biotechnology
National Taiwan University
College of Medicine
#7 Chung-Shan South Road
Taipei 100-02,TAIWAN
e-mail: whfang@ntu.edu.tw
M.C. Alejandra A. CANO HUÍZAR
CLEAR Consulting and Training Services
Loma Pareja 38, Bonanza
P. 58095, Morelia, Michoacán
MEXICO
e-mail:presidencia@conaquic.com
Dr. July KUMALAWATI
Clinical Pathology Department
Faculty of Medicine Universitas Indonesia
Dr. Cipto Mangunkusumo Hospital
Julan Diponegoro No. 69-71
Jakarta, 10430
INDONESIA
e-mail:julykw@gmail.com
Ms. Helen MARTIN
Chemical PAthology
SA Pathology
1 Frome Road, Adelaide
South Australia
AUSTRALIA
e-mail: Helen.Martin2@sa.gov.au
Dr. Sarah ROBINSON
Consultant Clinical Biochemist,Clinical Lead Biochemistry,
Deputy Clinical Director,
North Midlands and Cheshire Pathology Services
Leighton Hospital
Middlewich Road, Crewe, Cheshire, CW1 4QJ, UK
e-mail: sarah.robinson2@uhnm.nhs.uk
Dr. Aylin SEPICI DINCEL
Professor of Biochemistry
Department of Medical Biochemistry
Gazi University, Faculty of Medicine
Ankara, Turkey
email: asepicidincel@gmail.com
Prof. Christos TSATSANIS
Professor of Clinical Chemistry,
Medical School, University of Crete
Director, Clinical Chemistry Laboratory
University Hospital of Heraklion
Voutes, Heraklion 70013 Crete
GREECE e-mail:tsatsani@uoc.gr